Steris (STE) Tops Q3 EPS by 11c, provides guidance
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $224.59 -0.69%
EPS Growth %: +8.5%
Financial Fact:
Income tax expense (benefit): 7.15M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +8.5%
Financial Fact:
Income tax expense (benefit): 7.15M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q3 EPS of $2.47, $0.11 better than the analyst estimate of $2.36. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.43 billion.
GUIDANCE:
Steris sees FY2025 EPS of $10.15-$10.30, versus the consensus of $10.09.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
